Request Deal Involvement

Novo and Abingworth led a £90m Series A round in Myricx Bio.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Charles Consultants

pr advisors

Charles Consultants

Jones Day

legal advisors

Jones Day

or

Principals

MYRICX BIO

target

MYRICX BIO

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

ABINGWORTH MANAGEMENT

bidder

ABINGWORTH MANAGEMENT

BRITISH PATIENT CAPITAL

bidder

BRITISH PATIENT CAPITAL

CANCER RESEARCH HORIZONS

bidder

CANCER RESEARCH HORIZONS

BRANDON CAPITAL

bidder

BRANDON CAPITAL

SOFINNOVA PARTNERS

bidder

SOFINNOVA PARTNERS

ELI LILLY AND COMPANY

bidder

ELI LILLY AND COMPANY

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novo and Abingworth led a £90m Series A round in Myricx Bio.